Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients.

Balázs K, Kis E, Badie C, Bogdándi EN, Candéias S, Garcia LC, Dominczyk I, Frey B, Gaipl U, Jurányi Z, Kocsis ZS, Rutten EA, Sáfrány G, Widlak P, Lumniczky K.

Cancers (Basel). 2019 Sep 6;11(9). pii: E1324. doi: 10.3390/cancers11091324.

2.

It's more than low BMI: prevalence of cachexia and associated mortality in COPD.

McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, Bamman M, Celli B, Agusti A, Tal-Singer R, Hersh CP, Dransfield M, Silverman EK.

Respir Res. 2019 May 22;20(1):100. doi: 10.1186/s12931-019-1073-3.

3.

Left atrial spindle cell sarcoma: a case report.

Braams NJ, Kaffka Genaamd Dengler SE, Rutten EGGM, de Boer K.

Eur Heart J Case Rep. 2019 Feb 6;3(1):ytz005. doi: 10.1093/ehjcr/ytz005. eCollection 2019 Mar.

4.

Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging.

Triest FJJ, Franssen FME, Reynaert N, Gaffron S, Spruit MA, Janssen DJA, Rutten EPA, Wouters EFM, Vanfleteren LEGW.

J Clin Med. 2019 Apr 14;8(4). pii: E511. doi: 10.3390/jcm8040511.

5.

Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD.

Sprooten RTM, Lenaerts K, Braeken DCW, Grimbergen I, Rutten EP, Wouters EFM, Rohde GGU.

Respiration. 2018;95(5):334-342. doi: 10.1159/000485935. Epub 2018 Jan 25.

6.

Chest computed tomography-derived low fat-free mass index and mortality in COPD.

McDonald MN, Diaz AA, Rutten E, Lutz SM, Harmouche R, San Jose Estepar R, Kinney G, Hokanson JE, Gower BA, Wouters EFM, Rennard SI, Hersh CP, Casaburi R, Dransfield MT, Silverman EK, Washko GR.

Eur Respir J. 2017 Dec 14;50(6). pii: 1701134. doi: 10.1183/13993003.01134-2017. Print 2017 Dec.

7.

Physical activity patterns and clusters in 1001 patients with COPD.

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA.

Chron Respir Dis. 2017 Aug;14(3):256-269. doi: 10.1177/1479972316687207. Epub 2017 Feb 24.

8.

A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD.

van de Bool C, Rutten EPA, van Helvoort A, Franssen FME, Wouters EFM, Schols AMWJ.

J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):748-758. doi: 10.1002/jcsm.12219. Epub 2017 Jun 12.

9.

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.

Martin M, Almeras N, Després JP, Coxson HO, Washko GR, Vivodtzev I, Wouters EF, Rutten E, Williams MC, Murchison JT, MacNee W, Sin DD, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:451-460. doi: 10.2147/COPD.S124750. eCollection 2017.

10.

Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.

McDonald MN, Won S, Mattheisen M, Castaldi PJ, Cho MH, Rutten E, Hardin M, Yip WK, Rennard SI, Lomas DA, Wouters EFM, Agusti A, Casaburi R, Lange CP, O'Connor G, Hersh CP, Silverman EK.

J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):428-436. doi: 10.1002/jcsm.12171. Epub 2017 Jan 2.

11.

Anxiety, depression and autonomy-connectedness: The mediating role of alexithymia and assertiveness.

Rutten EA, Bachrach N, van Balkom AJ, Braeken J, Ouwens MA, Bekker MH.

Psychol Psychother. 2016 Dec;89(4):385-401. doi: 10.1111/papt.12083. Epub 2015 Oct 24.

PMID:
26499179
12.

Preliminary study on the assessment of visceral adipose tissue using dual-energy x-ray absorptiometry in chronic obstructive pulmonary disease.

De Blasio F, Rutten EP, Wouters EF, Scalfi L, De Blasio F, Akkermans MA, Spruit MA, Franssen FM.

Multidiscip Respir Med. 2016 Oct 4;11:33. eCollection 2016.

13.

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.

Reynaert NL, Gopal P, Rutten EPA, Wouters EFM, Schalkwijk CG.

Int J Biochem Cell Biol. 2016 Dec;81(Pt B):403-418. doi: 10.1016/j.biocel.2016.06.016. Epub 2016 Jun 29. Review.

PMID:
27373680
14.

Sarcopenic Obesity, Functional Outcomes, and Systemic Inflammation in Patients With Chronic Obstructive Pulmonary Disease.

Joppa P, Tkacova R, Franssen FM, Hanson C, Rennard SI, Silverman EK, McDonald ML, Calverley PM, Tal-Singer R, Spruit MA, Kenn K, Wouters EF, Rutten EP.

J Am Med Dir Assoc. 2016 Aug 1;17(8):712-8. doi: 10.1016/j.jamda.2016.03.020. Epub 2016 May 5.

PMID:
27161848
15.

A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience.

Spruit MA, Franssen FM, Rutten EP, Wopereis S, Wouters EF, Vanfleteren LE.

Eur Respir J. 2016 Apr;47(4):1024-7. doi: 10.1183/13993003.01645-2015. No abstract available.

16.

Comment on "Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study".

Rutten EP.

Respir Med. 2016 Mar;112:130. doi: 10.1016/j.rmed.2016.01.006. Epub 2016 Jan 21. No abstract available.

17.

The Relationship between Dietary Fiber Intake and Lung Function in the National Health and Nutrition Examination Surveys.

Hanson C, Lyden E, Rennard S, Mannino DM, Rutten EP, Hopkins R, Young R.

Ann Am Thorac Soc. 2016 May;13(5):643-50. doi: 10.1513/AnnalsATS.201509-609OC.

PMID:
26783997
18.

Reliability and validity of measures of impulsive choice and impulsive action in smokers trying to quit.

McCarthy DE, Bold KW, Minami H, Yeh VM, Rutten E, Nadkarni SG, Chapman GB.

Exp Clin Psychopharmacol. 2016 Apr;24(2):120-30. doi: 10.1037/pha0000061. Epub 2016 Jan 11.

19.

Effects of obesity on weight-bearing versus weight-supported exercise testing in patients with COPD.

Maatman RC, Spruit MA, van Melick PP, Peeters JP, Rutten EP, Vanfleteren LE, Wouters EF, Franssen FM.

Respirology. 2016 Apr;21(3):483-8. doi: 10.1111/resp.12700. Epub 2015 Dec 9.

20.

Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer.

Cobben DC, de Boer HC, Tijssen RH, Rutten EG, van Vulpen M, Peerlings J, Troost EG, Hoffmann AL, van Lier AL.

Technol Cancer Res Treat. 2016 Dec;15(6):NP47-NP60. Epub 2015 Nov 19. Review.

PMID:
26589726
21.

Differential response to pulmonary rehabilitation in COPD: multidimensional profiling.

Spruit MA, Augustin IM, Vanfleteren LE, Janssen DJ, Gaffron S, Pennings HJ, Smeenk F, Pieters W, van den Bergh JJ, Michels AJ, Groenen MT, Rutten EP, Wouters EF, Franssen FM; CIRO+ Rehabilitation Network.

Eur Respir J. 2015 Dec;46(6):1625-35. doi: 10.1183/13993003.00350-2015. Epub 2015 Oct 9.

22.

Continuous fat-free mass decline in COPD: fact or fiction?

Rutten EP, Spruit MA, McDonald ML, Rennard S, Agusti A, Celli B, Miller BE, Crim C, Calverley PM, Hanson C, MacNee W, Franssen FM, Vanfleteren L, Wouters EF; ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points) Investigators.

Eur Respir J. 2015 Nov;46(5):1496-8. doi: 10.1183/13993003.00692-2015. Epub 2015 Sep 17. No abstract available. Erratum in: Eur Respir J. 2016 Nov;48(5):1533.

23.

Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing.

Moberg M, Elango P, Ferrucci L, Spruit MA, Wouters EF, Rutten EP.

Eur J Clin Invest. 2015 Sep;45(9):955-63. doi: 10.1111/eci.12498. Epub 2015 Aug 7.

24.

Various Mechanistic Pathways Representing the Aging Process Are Altered in COPD.

Rutten EP, Gopal P, Wouters EF, Franssen FM, Hageman GJ, Vanfleteren LE, Spruit MA, Reynaert NL.

Chest. 2016 Jan;149(1):53-61. doi: 10.1378/chest.15-0645. Epub 2016 Jan 6.

PMID:
26066545
25.

New insights in chronic obstructive pulmonary disease and comorbidity.

Cleutjens F, Triest F, Wilke S, Vanfleteren LE, Franssen FM, Janssen DJ, Rutten EP, Spruit MA, Wouters EF.

Am J Respir Crit Care Med. 2015 May 1;191(9):1081-2. doi: 10.1164/rccm.201412-2296RR. No abstract available.

PMID:
25932764
26.

Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD.

van de Bool C, Rutten EP, Franssen FM, Wouters EF, Schols AM.

Eur Respir J. 2015 Aug;46(2):336-45. doi: 10.1183/09031936.00197314. Epub 2015 Apr 16.

27.

Fracture prevention in COPD patients; a clinical 5-step approach.

Romme EA, Geusens P, Lems WF, Rutten EP, Smeenk FW, van den Bergh JP, van Hal PT, Wouters EF.

Respir Res. 2015 Mar 7;16:32. doi: 10.1186/s12931-015-0192-8. Review.

28.

Influence of diet and obesity on COPD development and outcomes.

Hanson C, Rutten EP, Wouters EF, Rennard S.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 5;9:723-33. doi: 10.2147/COPD.S50111. eCollection 2014. Review.

29.

Prevalence of metabolic syndrome in COPD patients and its consequences.

Breyer MK, Spruit MA, Hanson CK, Franssen FM, Vanfleteren LE, Groenen MT, Bruijnzeel PL, Wouters EF, Rutten EP.

PLoS One. 2014 Jun 20;9(6):e98013. doi: 10.1371/journal.pone.0098013. eCollection 2014.

30.

GI symptoms in patients with COPD.

Rutten EP, Spruit MA, Franssen FM, Buurman WA, Wouters EF, Lenaerts K.

Chest. 2014 Jun;145(6):1437-8. doi: 10.1378/chest.14-0285. No abstract available.

PMID:
24889455
31.

The Association Between Dietary Intake and Phenotypical Characteristics of COPD in the ECLIPSE Cohort.

Hanson C, Sayles H, Rutten EEPA, Wouters EFM, MacNee W, Calverley P, Meza JL, Rennard S.

Chronic Obstr Pulm Dis. 2014 May 6;1(1):115-124. doi: 10.15326/jcopdf.1.1.2014.0113.

32.

New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank.

Franssen FM, Rutten EP, Groenen MT, Vanfleteren LE, Wouters EF, Spruit MA.

J Am Med Dir Assoc. 2014 Jun;15(6):448.e1-6. doi: 10.1016/j.jamda.2014.03.012. Epub 2014 Apr 20.

PMID:
24755478
33.

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD.

Gopal P, Reynaert NL, Scheijen JL, Schalkwijk CG, Franssen FM, Wouters EF, Rutten EP.

Respir Res. 2014 Feb 25;15:24. doi: 10.1186/1465-9921-15-24.

34.

Quality of dietary intake in relation to body composition in patients with chronic obstructive pulmonary disease eligible for pulmonary rehabilitation.

van de Bool C, Mattijssen-Verdonschot C, van Melick PP, Spruit MA, Franssen FM, Wouters EF, Schols AM, Rutten EP.

Eur J Clin Nutr. 2014 Feb;68(2):159-65. doi: 10.1038/ejcn.2013.257. Epub 2013 Dec 11.

PMID:
24327123
35.

Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation.

Vanfleteren LE, Spruit MA, Groenen MT, Bruijnzeel PL, Taib Z, Rutten EP, Op 't Roodt J, Akkermans MA, Wouters EF, Franssen FM.

Eur Respir J. 2014 May;43(5):1306-15. doi: 10.1183/09031936.00169313. Epub 2013 Dec 5.

36.

Associations between COPD related manifestations: a cross-sectional study.

Romme EA, McAllister DA, Murchison JT, Van Beek EJ, Petrides GS, Price CO, Rutten EP, Smeenk FW, Wouters EF, MacNee W.

Respir Res. 2013 Nov 19;14:129. doi: 10.1186/1465-9921-14-129.

37.

Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?

Rutten EP, Calverley PM, Casaburi R, Agusti A, Bakke P, Celli B, Coxson HO, Crim C, Lomas DA, Macnee W, Miller BE, Rennard SI, Scanlon PD, Silverman EK, Tal-Singer R, Vestbo J, Watkins ML, Wouters EF.

Ann Nutr Metab. 2013;63(3):239-47. doi: 10.1159/000353211. Epub 2013 Nov 7.

PMID:
24216978
38.

Detection of cervical cancer recurrence during follow-up: a multivariable comparison of 9 frequently investigated serum biomarkers.

Hoogendam JP, Zaal A, Rutten EG, Heijnen CJ, Kenter GG, Veldhuis WB, Verheijen RH, Zweemer RP.

Gynecol Oncol. 2013 Dec;131(3):655-60. doi: 10.1016/j.ygyno.2013.10.016. Epub 2013 Oct 22.

PMID:
24157617
39.

Osteoporosis in chronic obstructive pulmonary disease.

Romme EA, Smeenk FW, Rutten EP, Wouters EF.

Expert Rev Respir Med. 2013 Aug;7(4):397-410. doi: 10.1586/17476348.2013.814402. Epub 2013 Aug 16. Review.

PMID:
23952337
40.

Disturbed intestinal integrity in patients with COPD: effects of activities of daily living.

Rutten EPA, Lenaerts K, Buurman WA, Wouters EFM.

Chest. 2014 Feb;145(2):245-252. doi: 10.1378/chest.13-0584.

PMID:
23928850
41.

Moral orientation and relationships in school and adolescent pro- and antisocial behaviors: a multilevel study.

Wissink IB, Deković M, Stams GJ, Asscher JJ, Rutten E, Zijlstra BJ.

J Sch Nurs. 2014 Jun;30(3):216-25. doi: 10.1177/1059840513497402. Epub 2013 Jul 19.

PMID:
23873393
42.

Vitamin D, vitamin D binding protein, lung function and structure in COPD.

Berg I, Hanson C, Sayles H, Romberger D, Nelson A, Meza J, Miller B, Wouters EF, Macnee W, Rutten EP, Romme EA, Vestbo J, Edwards L, Rennard S.

Respir Med. 2013 Oct;107(10):1578-88. doi: 10.1016/j.rmed.2013.05.010. Epub 2013 Jul 1.

43.

Heterogeneity in clinical characteristics and co-morbidities in dyspneic individuals with COPD GOLD D: findings of the DICES trial.

Sillen MJ, Franssen FM, Delbressine JM, Uszko-Lencer NH, Vanfleteren LE, Rutten EP, Wouters EF, Spruit MA.

Respir Med. 2013 Aug;107(8):1186-94. doi: 10.1016/j.rmed.2013.04.020. Epub 2013 May 22.

44.

Diet and vitamin D as risk factors for lung impairment and COPD.

Hanson C, Rutten EP, Wouters EF, Rennard S.

Transl Res. 2013 Oct;162(4):219-36. doi: 10.1016/j.trsl.2013.04.004. Epub 2013 May 17. Review.

PMID:
23685188
45.

Vitamin D: beyond bone.

Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, Pittas AG, Boland R, Ferrucci L, Bikle DD.

Ann N Y Acad Sci. 2013 May;1287:45-58. doi: 10.1111/nyas.12129. Epub 2013 May 17.

46.

Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.

Gopal P, Reynaert NL, Scheijen JL, Engelen L, Schalkwijk CG, Franssen FM, Wouters EF, Rutten EP.

Eur Respir J. 2014 Feb;43(2):430-8. doi: 10.1183/09031936.00135312. Epub 2013 May 3.

47.

Bone stiffness and failure load are related with clinical parameters in men with chronic obstructive pulmonary disease.

Romme EA, Rutten EP, Geusens P, de Jong JJ, van Rietbergen B, Smeenk FW, Wouters EF, van den Bergh JP.

J Bone Miner Res. 2013 Oct;28(10):2186-93. doi: 10.1002/jbmr.1947.

48.

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):728-35. doi: 10.1164/rccm.201209-1665OC.

PMID:
23392440
49.

CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes.

Romme EA, Murchison JT, Edwards LD, van Beek E Jr, Murchison DM, Rutten EP, Smeenk FW, Williams MC, Wouters EF, MacNee W; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators.

J Bone Miner Res. 2013 Jun;28(6):1369-77. doi: 10.1002/jbmr.1873.

50.

Anemia is associated with bone mineral density in chronic obstructive pulmonary disease.

Rutten EP, Franssen FM, Spruit MA, Wouters EF.

COPD. 2013 Jun;10(3):286-92. doi: 10.3109/15412555.2012.744390. Epub 2012 Dec 28.

PMID:
23272661

Supplemental Content

Loading ...
Support Center